|
1
|
Kitamura K, Kangawa K, Kawamoto M, Ichiki
Y, Nakamura S, Matsuo H and Eto T: Adrenomedullin: A novel
hypotensive peptide isolated from human pheochromocytoma. 1993.
Biochem Biophys Res Commun. 425:548–555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheung BM, Li CY and Wong LY:
Adrenomedullin: Its role in the cardiovascular system. Semin Vasc
Med. 4:129–134. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Minamino N: Adrenomedullin, its
distribution and regulation of production. Nihon Rinsho. 62(Suppl
9): S193–S197. 2004.
|
|
4
|
Cheung BM and Tang F: Adrenomedullin:
Exciting new horizons. Recent Pat Endocr Metab Immune Drug Discov.
6:4–17. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wong HK, Cheung TT and Cheung BM:
Adrenomedullin and cardiovascular diseases. JRSM Cardiovasc Dis.
1:pii: cvd.2012.012003. 2012.PubMed/NCBI
|
|
6
|
Li Y, Jiang C, Wang X, Zhang Y, Shibahara
S and Takahashi K: Adrenomedullin is a novel adipokine:
Adrenomedullin in adipocytes and adipose tissues. Peptides.
28:1129–1143. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nishikimi T, Kuwahara K, Nakagawa Y,
Kangawa K and Nakao K: Adrenomedullin in cardiovascular disease: A
useful biomarker, its pathological roles and therapeutic
application. Curr Protein Pept Sci. 14:256–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arjamaa O: Physiology of natriuretic
peptides: The volume overload hypothesis revisited. World J
Cardiol. 6:4–7. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chowdhury P, Kehl D, Choudhary R and
Maisel A: The use of biomarkers in the patient with heart failure.
Curr Cardiol Rep. 15:3722013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clerico A, Giannoni A, Vittorini S and
Passino C: Thirty years of the heart as an endocrine organ:
Physiological role and clinical utility of cardiac natriuretic
hormones. Am J Physiol Heart Circ Physiol. 301:H12–H20. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Federico C: Natriuretic peptide system and
cardiovascular disease. Heart Views. 11:10–15. 2010.PubMed/NCBI
|
|
12
|
Kuhn M: Endothelial actions of atrial and
b-type natriuretic peptides. Br J Pharmacol. 166:522–531. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu WW and Qi YF: Cardiovascular effects
and pathophysiological significance of adrenomedullin family
peptides. Sheng Li Ke Xue Jin Zhan. 44:177–182. 2013.(In Chinese).
PubMed/NCBI
|
|
14
|
Whitworth JA: World Health Organization,
International Society of Hypertension Writing Group: 2003 World
Health Organization (WHO)/International Society of Hypertension
(ISH) statement on management of hypertension. J Hypertens.
21:1983–1992. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cotesta D, Caliumi C, Alò P, Petramala L,
Reale MG, Masciangelo R, Signore A, Cianci R, D'Erasmo E and
Letizia C: High plasma levels of human chromogranin a and
adrenomedullin in patients with pheochromocytoma. Tumori. 91:53–58.
2005.PubMed/NCBI
|
|
16
|
Ohta H, Tsuji T, Asai S, Tanizaki S,
Sasakura K, Teraoka H, Kitamura K and Kangawa K: A simple
immunoradiometric assay for measuring the entire molecules of
adrenomedullin in human plasma. Clin Chim Acta. 287:131–143. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ohta H, Tsuji T, Asai S, Sasakura K,
Teraoka H, Kitamura K and Kangawa K: One-step direct assay for
mature-type adrenomedullin with monoclonal antibodies. Clin Chem.
45:244–251. 1999.PubMed/NCBI
|
|
18
|
Yasue H, Yoshimura M, Sumida H, Kikuta K,
Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M and Nakao
K: Localization and mechanism of secretion of b-type natriuretic
peptide in comparison with those of A-type natriuretic peptide in
normal subjects and patients with heart failure. Circulation.
90:195–203. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Beltowski J and Jamroz A:
Adrenomedullin-what do we know 10 years since its discovery? Pol J
Pharmacol. 56:5–27. 2004.PubMed/NCBI
|
|
20
|
Kato J, Kitamura K and Eto T: Plasma
adrenomedullin level and development of hypertension. J Hum
Hypertens. 20:566–570. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garcia MA, Martín-Santamaría S, de
Pascual-Teresa B, Ramos A, Julián M and Martínez A: Adrenomedullin:
A new and promising target for drug discovery. Expert Opin Ther
Targets. 10:303–317. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marín MR, Arenas MF, Valverde FM, Garaulet
ET, Maderuelo MM, Avilés AM, Quirante FP and Blázquez AA:
Laparoscopic adrenalectomy for nonfamilial adrenal medullary
hyperplasia. JSLS. 17:433–439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thouennon E, Pierre A, Yon L and Anouar Y:
Expression of trophic peptides and their receptors in chromaffin
cells and pheochromocytoma. Cell Mol Neurobiol. 30:1383–1389. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sergeeva IA and Christoffels VM:
Regulation of expression of atrial and brain natriuretic peptide,
biomarkers for heart development and disease. Biochim Biophys Acta.
1832:2403–2413. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saito Y: Roles of atrial natriuretic
peptide and its therapeutic use. J Cardiol. 56:262–270. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nishikimi T: Adrenomedullin in essential
hypertension. Nihon Rinsho. 62(Suppl 9): S260–S263. 2004.(In
Japanese).
|
|
27
|
Soualmia H, Ayadi I, Omar S, Feki M,
Drissa H, Mebazaa A and Kaabachi N: Atrial natriuretic peptide and
brain natriuretic peptide release in human essential hypertension.
Clin Lab. 55:120–127. 2009.PubMed/NCBI
|
|
28
|
Lee YJ, Lin SR, Shin SJ, Lai YH, Lin YT
and Tsai JH: Brain natriuretic peptide is synthesized in the human
adrenal medulla and its messenger ribonucleic acid expression along
with that of atrial natriuretic peptide are enhanced in patients
with primary aldosteronism. J Clin Endocrinol Metab. 79:1476–1482.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Letizia C, De Toma G, Cerci S, Massa R,
Coassin S, Subioli S, Scuro L and De Ciocchis A: Adrenomedullin
levels are high in primary aldosteronism due to adenoma and decline
after surgical cure. Blood Press. 7:19–23. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kato J, Etoh T, Kitamura K and Eto T:
Atrial and brain natriuretic peptides as markers of cardiac load
and volume retention in primary aldosteronism. Am J Hypertens.
18:354–357. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Letizia C, De Toma G, Caliumi C, Cerci S,
Massa R, Loria RD, Alo P, Marinoni EM, Diacinti D and D'Erasmo E:
Plasma adrenomedullin concentrations in patients with adrenal
pheochromocytoma. Horm Metab Res. 33:290–294. 2001. View Article : Google Scholar : PubMed/NCBI
|
